Research

Incovacc is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein

The medication is designed to target a mutated form of a gene known as KRAS that occurs in about 13 per cent of non-small cell…

The US-based National Institute of Health (NIH) to gather data on tecovirimat (TPOXX)

Manuj Vangipurapu, founder and CEO, Clinion, briefly discusses the many well-known and lesser-known uses of AI and automation in…

The results from the trial, which was led by TB Alliance, were published in the 'New England Journal of Medicine'

To study the SARS-CoV-2 virus, the researchers need to isolate the virus from the samples, create multiple copies of it, and…

Oxemia (Desidustat) is a prescription drug approved in India for patients with Chronic Kidney Disease (CKD)-induced anaemia, and…

Researchers have developed biodegradable nanoparticles from renewable resources which can release both hydrophilic and hydrophobic…

As per a study, published in the journal 'EMBO Molecular Medicine,' the vaccine showed promising results in mice, and the…

Although there are vaccines developed for the closely related smallpox that can reduce the risk of catching monkeypox, there are…

The study, presented at ESC Congress 2022, found that the vaccines were not associated with an increased risk of worsening heart…

New data from Olympia phase-III trial suggest that Olaparib demonstrated a statistically significant and clinically meaningful…

The widely available diabetes drug metformin may reduce the risk of emergency room visits, hospitalisation, and death from…

Researchers at Massachusetts General Hospital (MGH) in the US found that 12.5 per cent of placebo-treated individuals and one per…

The failure in the latest trial, called Canopy A, is a setback for Novartis after canakinumab failed in two separate studies last…

Data from both phase-III human clinical trials have been submitted for approval to National Regulatory Authorities

MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop resistance to targetted therapy

The findings are the first indication of how well Lumakras works in combination with drugs that help the immune system attack…

Decision follows results of interim futility analysis which indicate phase-III REALM-DCM trial unlikely to meet primary endpoint

Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan…